Warning letter
Shrock, John E.: warning letter of Sep 3, 2008
FDA warning letter UCM1048145 · Cincinnati District Office
Key facts
| Reference number | UCM1048145 |
|---|---|
| Company | Shrock, John E. |
| Subject | Illegal Drug Residue |
| Issue date | Sep 3, 2008 |
| Posted date | Sep 3, 2008 |
| Issuing office | Cincinnati District Office |
| Product type | Drugs |
| CFR sections cited | 556.670, 530.11(a), 530.11(d), 530, 530.3(a) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: